Advertisement
In a clinical practice guideline published online Jan. 31 in the Journal of Clinical Endocrinology and Metabolism

Clinical Practice Guidelines Developed for Pediatric Obesity

0
Recommendations developed for assessment, treatment, and prevention of pediatric obesity
A high fasting triglyceride level combined with a low high-density lipoprotein cholesterol level is associated with increased risks of incident coronary heart disease and ischemic stroke

High TG, Low HDL-C Levels May Help Further Stratify CHD Risk

0
Fasting high TG + low HDL associated with increased risk, particularly in those with diabetes
From 2000 to 2014 there was an increase in the rate of vitamin D deficiency diagnosis among children

2000 to 2014 Saw Increase in Vitamin D Deficiency in Children

0
15-fold increase in diagnosis from 2008 to 2014 after accounting for demographic changes
Successful lumbar surgery is associated with improved glycemic control for patients with lumbar spinal stenosis and type 2 diabetes mellitus

Surgery Can Benefit T2DM Control for Patients With Lumbar Stenosis

0
Post-op HbA1c changes linked to improvement in Oswestry Disability Index, JOA, JOABPEQ scores

January 2017 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2017. This roundup includes...
For youth with type 1 diabetes

HbA1c, Waist-to-Height Ratio Predict Dyslipidemia in T1DM

0
For youth with type 1 diabetes, hemoglobin A1c and waist-to-height ratio are modifiable risk factors
Attempts to shame an overweight or obese person into losing weight won't motivate them to do so

Obese Who Self-Stigmatize May Have Higher Cardiometabolic Risk

0
Those affected by weight bias more likely to have cardiovascular disease risk factors
Developing or worsening type 2 diabetes could be an early sign of pancreatic cancer

New or Worsening T2DM Could Indicate Pancreatic Cancer

0
Type 2 diabetes could be the first sign of hidden pancreatic cancer, researchers say
For patients with type 1 diabetes

Insulin Glargine 300 U/mL Beats Glargine 100 U/mL in T1DM

0
Smoother average 24-hour glucose profile with Gla-300 versus Gla-100, regardless of injection time
Use of growth hormone in children and adolescents should be considered carefully

Guidelines Developed for Use of Growth Hormone in Children

0
Guidance provided for children with idiopathic short stature, GH deficiency, primary IGF-I deficiency